Latest Kaiser Health News Stories
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
The Food and Drug Administration rarely prosecutes research violations, but its criminal division is looking into the experimental herpes vaccine research by Southern Illinois University professor William Halford.
Three participants in unauthorized herpes vaccine research file a lawsuit against scientist’s company, alleging adverse side effects.
Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.
The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
Southern Illinois University has concluded its researcher violated university rules and U.S. law.
Southern Illinois University’s William Halford conducted unregulated human herpes experiments in hotels near university campus, emails show.
Patients flocked to researcher who ignored usual patient protections, as university claimed ignorance.
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Rep. Chris Collins’ enthusiastic investments in Australian biotech company Innate Immunotherapeutics preceded share purchases by the Buffalo Republican’s family members, associates and political donors — raising questions from Washington, D.C., to Sydney.
Pricey and unproven therapies that sound too good to be true probably are.
Researchers examine the Food and Drug Administration’s “revolving door” regarding employees who worked on cancer and hematology drugs.
Some clinics on NIH’s website charge people to participate in testing of unproven treatments — and it can come as a surprise to unsuspecting patients.